These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Drug interactions in the treatment of arterial hypertension: an emerging problem]. Casiglia E; Gava R; Giacomello M; Cima L; Giusti P; Pessina AC Clin Ter; 1987 Nov; 123(3):177-83. PubMed ID: 2902951 [No Abstract] [Full Text] [Related]
5. Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties. Herbette LG; Vecchiarelli M; Sartani A; Leonardi A Blood Press Suppl; 1998; 2():10-7. PubMed ID: 9850437 [TBL] [Abstract][Full Text] [Related]
6. [Principles of the pharmacokinetics and pharmacodynamics of calcium antagonists]. Rameis H Wien Med Wochenschr; 1993; 143(19-20):490-500. PubMed ID: 8135031 [TBL] [Abstract][Full Text] [Related]
8. Interaction of some drugs on the pharmacokinetics or pharmacodynamics of MPC-1304, a dihydropyridine Ca2+ antagonist. Nakano M; Miyoshi K; Umeno Y; Yoshida K; Nishizaki J; Miyake H Arch Int Pharmacodyn Ther; 1996; 331(2):109-23. PubMed ID: 8937623 [TBL] [Abstract][Full Text] [Related]
9. Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers. Höcht C; Bertera FM; Mayer MA; Taira CA Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):199-211. PubMed ID: 20095790 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetic interaction of drugs with cardiac glycosides; which are clinically important?]. Hooymans PM; Merkus FW Ned Tijdschr Geneeskd; 1986 Mar; 130(9):395-9. PubMed ID: 2870436 [No Abstract] [Full Text] [Related]
11. [Interactions between anti-hypertensive and non-antihypertensive drugs]. Sugimoto T; Matsuoka H Nihon Rinsho; 1992 May; 50 Suppl():28-33. PubMed ID: 1355128 [No Abstract] [Full Text] [Related]